Open Access

Activation of formate hydrogen-lyase via expression of uptake [NiFe]-hydrogenase in Escherichia coli BL21(DE3)

Microbial Cell Factories201514:151

https://doi.org/10.1186/s12934-015-0343-0

Received: 12 July 2015

Accepted: 16 September 2015

Published: 22 September 2015

Abstract

Background

Several recent studies have reported successful hydrogen (H2) production achieved via recombinant expression of uptake [NiFe]-hydrogenases from Hydrogenovibrio marinus, Rhodobacter sphaeroides, and Escherichia coli (hydrogenase-1) in E. coli BL21(DE3), a strain that lacks H2-evolving activity. However, there are some unclear points that do not support the conclusion that the recombinant hydrogenases are responsible for the in vivo H2 production.

Results

Unlike wild-type BL21(DE3), the recombinant BL21(DE3) strains possessed formate hydrogen-lyase (FHL) activities. Through experiments using fdhF (formate dehydrogenase-H) or hycE (hydrogenase-3) mutants, it was shown that H2 production was almost exclusively dependent on FHL. Upon expression of hydrogenase, extracellular formate concentration was changed even in the mutant strains lacking FHL, indicating that formate metabolism other than FHL was also affected. The two subunits of H. marinus uptake [NiFe]-hydrogenase could activate FHL independently of each other, implying the presence of more than two different mechanisms for FHL activation in BL21(DE3). It was also revealed that the signal peptide in the small subunit was essential for activation of FHL via the small subunit.

Conclusions

Herein, we demonstrated that the production of H2 was indeed induced via native FHL activated by the expression of recombinant hydrogenases. The recombinant strains with [NiFe]-hydrogenase appear to be unsuitable for practical in vivo H2 production due to their relatively low H2 yields and productivities. We suggest that an improved H2-producing cell factory could be designed by constructing a well characterized and overproduced synthetic H2 pathway and fully activating the native FHL in BL21(DE3).

Keywords

Recombinant hydrogenase Escherichia coli BL21(DE3) Biohydrogen Formate hydrogen lyase Hydrogenovibrio marinus

Background

Hydrogen (H2) production via biological means has been considered as a potential source of alternative fuel due to clean and truly renewable processes [1]. Hydrogenases are the key enzymes in microbial H2 metabolism that catalyze the reversible reduction of protons with electrons [2]. Certain limitations of native hydrogenase systems for H2 production (i.e., problems related to substrate (electron donor/acceptor) specificity, oxygen (O2) sensitivity, catalytic bias to H2 oxidation, electron partitioning, etc.) have been reported in microorganisms [3], and their properties appear to be unable to meet current needs. Therefore, expression and engineering of hydrogenases in heterologous hosts is generally accepted as the most influential approach to modification of enzyme qualities and H2 production efficiency for biotechnological applications [3, 4]. Recombinant expression of hydrogenase not only provides the ability to engineer the H2 metabolism of the host for specific purposes but also could facilitate basic studies on the maturation process of the complex metalloenzyme [4].

Escherichia coli has been widely used as a host microbe for protein expression [5]. This bacterium was also adopted for expression of recombinant hydrogenase in several studies, either for study of hydrogenase maturation or for improvement of fermentative H2 production by coupling to the native electron transfer system of E. coli [610]. In particular, the strain BL21(DE3) (or BL21), which is an optimized host for protein overexpression, can neither produce nor consume H2 (no hydrogenase activity) under the general culture conditions where K-12 derivatives do possess the abilities [1114]. This observation prompted certain researchers to consider this strain as an ideal host for hydrogenase expression and testing for in vivo H2 production [1214].

According to the composition of bimetallic active sites, hydrogenases are broadly classified into [FeFe]- and [NiFe]-hydrogenases from the standpoint of biotechnological importance. E. coli contains four different [NiFe]-hydrogenases, and among those, hydrogenase-3 is responsible for H2 production during mixed-acid fermentation [15]. This enzyme forms a formate hydrogen-lyase (FHL) complex together with formate dehydrogenase-H, one of the three formate dehydrogenases of E. coli [16].

Recently, certain studies reported that homologous or heterologous expression of the structural (large and small) subunits of uptake [NiFe]-hydrogenases resulted in construction of recombinant BL21(DE3) derivatives that are capable of producing H2 [1719]. However, some unclear points arise that do not support the conclusion that the expressed hydrogenases are indeed responsible for the in vivo H2 production of the recombinant strains. Among these points, the most critical is that all of the engineered hydrogenases engage in H2 uptake (consumption) and not production in their native hosts [2022]. In this work, we tackle this problem using simple biochemical and mutant experiments. We suggest that H2 production in such recombinant systems is almost exclusively dependent on the native FHL of E. coli, and thus, careful characterization of the recombinant hydrogenase systems in BL21(DE3) is required, especially for those designed for in vivo H2 production.

Results and discussion

Activation of FHL activity in recombinant strains

Several efforts have been put forth to engineer uptake [NiFe]-hydrogenases in BL21(DE3) strain [1719]. In these studies, H2 production was demonstrated by expressing structural (large and small) subunits of the hydrogenases in the non-H2 producing E. coli strain, and the authors concluded that the engineered, non-native hydrogenases could be used as tools to enhance biohydrogen production in E. coli. However, a critical discussion promptly arises related to the fundamental origin of the produced H2: (1) The engineered hydrogenases are engaged in H2 uptake and not in H2 production in their native hosts, which means that standard redox potentials of their respective electron acceptors (e.g., cytochrome b) are expected to be much higher than that of H2 (−420 mV) [23]. Additionally, uptake [NiFe]-hydrogenases generally show high catalytic bias to H2 oxidation [24, 25]. Thus, even if an uptake [NiFe]-hydrogenase is ‘wired’ to an electron transport system in E. coli, H2 produced via the non-native pathway is not expected to highly accumulate in a closed batch culture system [12], which is in contrast to the results of high H2 accumulation in the previous studies [1719]. (2) Addition of hypophosphite, an inhibitor of pyruvate formate-lyase, abolished the H2 production in a recombinant strain expressing E. coli HyaBA (hydrogenase-1) [19]. Moreover, addition of formate greatly increased in vivo H2 production. (3) Full maturation of the expressed hydrogenases is questionable because maturation of [NiFe]-hydrogenase further requires highly specific auxiliary proteins [26].

Putting the theoretical and the experimental clues together, we hypothesized that the BL21(DE3) derivatives produce H2 via a native FHL pathway that is activated by the expression of the recombinant hydrogenases. A test for H2 production using formate as a sole electron source showed that the recombinant strains with the heterologous (H. marinus HoxGK and R. sphaeroides HupSL) or homologous (E. coli HyaBA) hydrogenase indeed showed FHL activity, whereas the negative control strain with the parental empty vector exhibited negligible FHL activity as expected (Fig. 1). When we measured formate consumption by the strain with H. marinus HoxGK, it was found that the cells consumed 1.6 ± 0.1 mM formate, whose corresponding calculated H2 production (3.58 mL) well coincides with the actual amount of H2 production (3.23 mL). In contrast, the negative control cells showed virtually no consumption of formate (0.0 ± 0.1 mM). These results imply that the FHL pathway was at least partially responsible for the observed in vivo H2 production in the previously reported recombinant strains.
Fig. 1

FHL activation in E. coli BL21(DE3). Recombinant cells harboring each hydrogenase were cultured in PBS buffer supplemented with 20 mM sodium formate, and H2 production from formate was measured after 13 h. H.ma, Hydrogenovibrio marinus; R.sp, Rhodobacter sphaeroides; E.co, Escherichia coli; (−), negative control strain with parental empty vector (pTrcHis C)

FHL dependency of H2 production in the recombinant strains

Measurement of FHL activity was not sufficient to decide whether H2 production in the recombinant strains originates exclusively from the activated FHL pathway. To examine the FHL-dependency, we constructed two knockout BL21(DE3) strains lacking formate dehydrogenase-H (fdhF) and hydrogenase-3 (hycE), respectively, both of which constitute essential components of the FHL complex [16] and subsequently tested in vivo H2 production by expressing the recombinant hydrogenases.

In the case of the fdhF mutant, all mutant strains produced small amounts of H2 that were roughly comparable to that of the negative control (Fig. 2), which clearly demonstrated that H2 was produced from formate as the only major substrate in the previous reported recombinant strains [1719]. Similarly, insignificant amounts of H2 were produced by hycE mutants, which indicates that hydrogenase-3 was almost entirely responsible for H2 production in the reported BL21(DE3) derivatives (Fig. 2). Although H2 production by both of the mutants with H. marinus HoxGK was slightly exceptional (2.1-fold for fdhF mutant and 7.5-fold for hycE mutant compared with the negative controls), the amounts can still be considered marginal compared with the positive control. It appears that the expression of HoxGK influenced the other E. coli hydrogenase system(s) to evolve H2 because H2 was not detected when the E. coli MW1001 strain lacking hydrogenase-1, hydrogenase-2, and hydrogenase-3 was transformed with pTrcHoxGK (data not shown). Thus, we concluded that H2 was produced almost exclusively via the activated FHL pathway in the BL21(DE3) strains with the recombinant hydrogenases. We strongly suspect that the recent report on H2 production in BL21(DE3) by expression of Rhodopseudomonas palustris [NiFe]-hydrogenase [27] falls within this category. It is noteworthy that all recombinant [NiFe]-hydrogenases that activated FHL belong to Group 1 according to the widely used classification of hydrogenases [28].
Fig. 2

H2 production in FHL-deficient mutant BL21(DE3) strains. Strains lacking formate dehydrogenase-H or hydrogenase-3 were used. H.ma, Hydrogenovibrio marinus; R.sp, Rhodobacter sphaeroides; E.co, Escherichia coli; (−), negative control mutant with parental empty vector (pTrcHis C); (+), positive control strain with R. sphaeroides HupSL

After in vivo H2 production in the wild-type and the mutant BL21(DE3) strains with H. marinus HoxGK, extracellular formate concentrations were measured and compared with those of negative controls (Table 1). All of the strains with the parent vector showed similar formate level regardless of the FHL mutations. This is not surprising because formate consuming pathways are already impaired in BL21(DE3) [11]. On the other hand, when H. marinus HoxGK was expressed, the formate concentration of wild-type BL21(DE3) was lower than those of the mutant strains, indicating that formate was consumed for H2 production. Notably, the overall formate level was lowered upon the expression of hydrogenase even in the mutants that cannot produce H2, which implies that formate metabolism (either production or consumption) other than FHL pathway was also affected by the expression of recombinant hydrogenase.
Table 1

Extracellular concentration of formate (mM) measured after in vivo H2 production in BL21(DE3) derivatives

Plasmid

Strain

Wild-type

ΔfdhF

ΔhycE

pTrcHis C

15.9 ± 0.3

16.5 ± 0.1

16.1 ± 0.4

pTrcHoxGK

10.6 ± 0.2

13.3 ± 1.1

13.1 ± 1.4

Involvement of each subunit in FHL activation

In an effort to reveal the role of uptake [NiFe]-hydrogenase in FHL activation, we investigated the contribution of each subunit to H2 production using H. marinus hydrogenase as a model enzyme. Expression vectors were constructed for five different combinations of the large subunit (HoxG), small subunit (HoxK), and small subunit without signal peptide (HoxK*) (Fig. 3a), and all of the subunits with His6-tag were successfully expressed in E. coli BL21(DE3) (Fig. 3b). As shown in Fig. 3c, different amounts of H2 were produced by the different combinations. This pattern of H2 production was well correlated with FHL activity (R 2 > 0.99) (Fig. 3d), implying that the different amounts of H2 production was due to different degrees of FHL activation. Intriguingly, H2 production was observed in the recombinant strains with HoxG or HoxK alone (Fig. 3c). Because the catalytic active site of [NiFe]-hydrogenase is located in large subunit [28], the result of H2 production with only the small subunit corroborates the previous conclusion that the recombinant hydrogenase was not the catalyst that produced H2 in BL21(DE3). Notably, the effects of the two subunits seemed to be additive (Fig. 3c), possibly representing the presence of more than two separate mechanisms for FHL activation. The fact that H2 was produced with HoxG alone also supports this possibility.
Fig. 3

Combinatorial expressions of hydrogenase subunits of H. marinus in BL21(DE3). a Construction of expression vectors. The constructed vectors (from top to bottom) are pTrcHoxG, pTrcHoxK, pTrcHoxGK, pTrcHoxGK*, and pTrcHoxK*, respectively. b Western blot analysis. Anti-His6 antibody was used. c H2 production. d FHL activation. H2 production from formate was measured after 18-h incubation. RBS ribosome binding site, His 6 hexahistidine tag sequence, SP sequence for signal peptide, HoxK* HoxK without signal peptide

The deletion of signal sequence on HoxK resulted in no H2 production, indicating that the signal peptide was essential for FHL activation via the small subunit (Fig. 3c). This observation is consistent with the previous report, in which the importance of signal peptide on in vivo H2 production was shown [17]. Because the signal peptide is implicated in the interaction with membrane component(s) for protein translocation [29], it is likely that the mechanism by which the small subunit activates FHL involves a membrane component that directly or indirectly affects FHL, which is also a membrane protein complex [16].

A recent study on metabolic deficiencies of BL21(DE3) suggested that the lack of FHL activity in BL21(DE3) can be restored by complementation of a wild type copy of fnr gene and a high concentration of metal ions (500 μM nickel and 1 mM molybdenum) [11]. In our experiments, no additional ions were added except for 30 μM nickel and iron, and little possibility exists that the expressed subunits can function as FNR. Additionally, the effect of FHL restoration by FNR was only partial when compared with the FHL activity of E. coli K-12 strains [11]. Intriguingly, an fnr mutant of K-12 strain (PB1000) still possessed 20 % FHL activity of the parent strain [11]. Thus, although we do not offer any clear explanation of how the subunits activate FHL, we suggest the existence of an unknown pathway(s) for FHL activation and regulation of formate metabolism that is distinct from the fnr-mediated activation.

Implications for future research

The main purpose of engineering hydrogenase or its relevant pathway is to enhance H2 yield and/or productivity. Because H2 production in the recombinant BL21(DE3) strains almost entirely depends on native FHL, in principle, the yield cannot exceed the theoretical maximal H2 yield from formate (2 mol-H2/mol-glucose) that has been almost realized with E. coli K-12 mutant (Table 2). In terms of productivity, the recombinant strains are also much less effective than previously constructed K-12 derivatives (Table 2). Therefore, in their present form, the reported BL21(DE3) strains with the recombinant uptake [NiFe]-hydrogenases appear to be poorly suited for practical in vivo H2 production unless non-native FHL-independent H2 pathways are constructed with the recombinant hydrogenases using synthetic biology and/or metabolic engineering approaches. Thus, we suggest that recombinant hydrogenase systems designed for in vivo H2 production should be carefully characterized, especially if E. coli BL21(DE3) is used as a host; mere observation of in vivo H2 production doesn’t imply successful construction of non-native H2 pathway.
Table 2

Comparison of H2 production by E. coli strains

Host

Genetic modification

H2 yield (mol-H2/mol-glucose)

H2 productivity (mL-H2/L-culture h)

References

E. coli BL21(DE3)

H. marinus hoxGK

0.65

25.1

[17]

E. coli BL21(DE3)

R. sphaeroides hupSL

0.28

19.7

[18]

E. coli BL21(DE3)

E. coli hyaBA

0.32

12.5

[19]

E. coli BL21(DE3)

R. palustris hupSL

0.32

39.9

[27]

E. coli BW25113

ΔhycA ΔhyaAB ΔhybBC ΔldhA ΔfrdAB

1.80

420.7

[30, 31]

E. coli BW25113

ΔhyaB ΔhybC ΔhycA ΔfdoG ΔfrdC ΔldhA ΔaceE

1.32

354.8

[32]

E. coli BL21(DE3) is an important strain as a general choice for overexpression of recombinant proteins [5] and holds promise for metabolic engineering and biofuel production. Complete elucidation of the mechanisms for FHL activation in BL21(DE3) is important because it could enable the efficient expansion of H2 yield with high productivity in E. coli; H2 might be produced using more than two substrates simultaneously in BL21(DE3) e.g., via the fully activated FHL pathway and the other FHL-independent H2 pathway that is robustly constituted by recombinant overexpression of H2 metabolizing enzymes [8].

Conclusions

In this study, the H2 production pathway was investigated in recombinant E. coli BL21(DE3) strains that express the structural subunits of uptake [NiFe]-hydrogenase from H. marinus (HoxGK), R. sphaeroides (HupSL), or E. coli (HyaBA). The recombinant strains clearly showed FHL activity, whereas the wild-type strain did not. The H2 production was not observed in the recombinant strains lacking fdhF or hycE, thus demonstrating exclusive dependence of the H2 production on activated native FHL. Formate level was changed upon expression of hydrogenase even in the mutant strains lacking FHL, indicating that formate metabolism other than FHL was also affected. Through combinatorial expression of hydrogenase subunits, it was shown that each subunit could activate FHL independently. In addition, it was revealed that the signal peptide is required for FHL activation by the small subunit. The FHL dependence of the recombinant BL21(DE3) derivatives fundamentally limits the practical use of the strains in applications for biohydrogen production. A more effective system might be constructed by synergetic combination of an overproduced synthetic H2 pathway with the fully activated FHL pathway in E. coli BL21(DE3).

Methods

Strains and plasmid construction

The strains, plasmids, and primers used in this study are listed in Table 3. All of the DNA works were performed using E. coli TOP10 (Invitrogen, USA), and E. coli BL21(DE3) (Novagen, USA) was used for hydrogenase expression and H2 production. The plasmid for expression of Rhodobacter sphaeroides HupSL (pEMBTL-HJ2) [18] and the E. coli mutant strain MW1001 [33] were kindly provided by Dr. Jiho Min (Chonbuk National University, Jeonju, Korea) and Dr. T. K. Wood (Texas A & M University, Texas, USA), respectively. The vectors for expression of the hydrogenase subunits of Hydrogenovibrio marinus [34] were constructed by polymerase chain reaction (PCR)-based cloning procedures using genomic DNA of H. marinus (DSM 11271) and the listed primers with NheI, NcoI, XhoI, or PstI restriction sites. The PCR products were inserted into the pGEM-T Easy vector (Promega, USA) prior to subcloning into pTrcHis C (Invitrogen). For polycistronic expression of both hydrogenase subunits, the primers hoxK_poly and hoxK*_poly were designed to contain an intergenic sequence with a ribosome binding site (RBS), a slightly modified portion of the intergenic sequence between lacZ and lacY found in the E. coli genome. The plasmid pTrcHoxGK was primarily used throughout the study for expression of H. marinus hydrogenase. E. coli cells were grown and maintained in Luria–Bertani (LB) medium (Usb Corp., USA) supplemented with the appropriate antibiotics (ampicillin, 50 μg/mL; streptomycin or kanamycin, 10 μg/mL) at 37 °C in a shaking incubator at 220 rpm (Jeiotech, Korea).
Table 3

E. coli strains, plasmids, and primers used in this study

Strains, plasmids, or primers

Genotypes, relevant characteristics, or sequences

Source or references

Strains

 TOP10

F mcrA Δ(mrr-hsdRMS-mcrBC) Ф80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG, streptomycin-resistant

Invitrogen

 BL21(DE3)

F- ompT hsdS B(r B m B ) gal dcm λ(DE3), carrying the T7 RNA polymerase gene

Novagen

 JH0

BL21(DE3) ΔfdhF::FRT-kan-FRT

This study

 JH1

BL21(DE3) ΔhycE::FRT-kan-FRT

This study

 MW1001

lacI q rrnB T14 ΔlacZ WJ16 hsdR514 ΔaraBAD AH33 ΔrhaBAD LD78 ΔhyaB ΔhybC ΔhycE

[33]

Plasmids

 pGEM-T Easy

bla lacZ, TA cloning vector

Promega

 pEMBTL-HJ2

Expression vector with T7 promoter carrying R. sphaeroides hupS and hupL

[18]

 pTrc-EcH1ABHis

Expression vector with trc promoter carrying E. coli hyaB and hyaA

[19]

 pTrcHis C

pBR322 ori bla lacI q , a parental expression vector with trc promoter

Invitrogen

 pTrcHoxGK

pTrcHis C carrying H. marinus hoxG and hoxK

This study

 pTrcHoxG

pTrcHis C carrying H. marinus hoxG

This study

 pTrcHoxK

pTrcHis C carrying H. marinus hoxK

This study

 pTrcHoxGK*

pTrcHis C carrying H. marinus hoxG and hoxK without signal sequence

This study

 pTrcHoxK*

pTrcHis C carrying H. marinus hoxK without signal sequence

This study

 pKD46

bla γ β exo araC, Red recombinase vector containing temperature-sensitive replicon

CGSC

 pKD13

bla FRT-kan-FRT, template plasmid used for Red recombination

CGSC

Primersa

 hoxG

Forward: GCTAGC ATGAGCGTATTAAACACACC (NheI)

Reverse: CTCGAG TTATCGAACCTTGACGGT (XhoI)

This study

 hoxK_poly

Forward: CTCGAGTCTGCCCGTATTGCGCGTAAGGAAATCCATTATGTCAT CTCAAGTTGAAAC (XhoI)

Reverse: CTGCAGTCAATGGTGATGGTGATGATGACCGCCTTTATCTCCTT TCTTTTGAGCC (PstI)

This study

 hoxK*_poly

Forward: CTCGAGTCTGCCCGTATTGCGCGTAAGGAAATCCATTATGGCG AACAAAATTGCTCATGCGAT (XhoI)

Reverse: ditto

This study

 hoxK

Forward: CCATGGGCTCATCTCAAGTTGAAACGTT (NcoI)

Reverse: ditto

This study

 hoxK*

Forward: CCATGGGCAACAAAATTGCTCATGCGAT (NcoI)

Reverse: ditto

This study

 fdhF13

Forward: CAATCACGTACTGCTCGGCGGCGCGCTGATCGGCGATCGGCTCG ACGCGCATTCCGGGGATCCGTCGACC

Reverse: TCCTGACCCCGCGCCTGAAAACCCCCATGATCCGTCGCCAGCGT GGCGGCTGTAGGCTGGAGCTGCTTCG

This study

 hycE13

Forward: TTTTTGATAAAGGTAAACATGGCGATTCCTTATTTCAGCGGCGA GTTTTTATTCCGGGGATCCGTCGACC

Reverse: TTAGCGTTCGTCTCCTTGCTGGCGGCGTGATTAAAGAGAGTTTG AGCATGTGTAGGCTGGAGCTGCTTCG

This study

 fdhFchk

Forward: GTAGGGAGTAACCAGTATAA

Reverse: AATGACCCCACATAAAATGT

This study

 hycEchk

Forward: CCAGCGGATAAGACGAGGT

Reverse: CGTCTTGATATTACTCCGCG

This study

aRegions that hybridize to the corresponding template sequences are bolded, and restriction sites are underlined

Construction of mutant strains

The Red recombination system with pKD46 (Coli Genetic Stock Center (CGSC), USA) was adopted for inactivation of chromosomal fdhF or hycE gene in E. coli BL21(DE3). A gene construct composed of kanamycin resistance gene (kan) flanked by FLP recognition target (FRT) sites on pKD13 (CGSC) was amplified by PCR using fdhF- or hycE-specific primers with 50-nt homology extensions. Gene disruption was performed as described in [35] and confirmed by PCR using specific primers that were designed based on the sequences flanking the disrupted region of the genome. The kan gene was not cured to avoid contamination in cell culture.

In vivo H2 production

The recombinant E. coli BL21(DE3) derivatives transformed with the expression vectors were cultured in 100 mL of M9 media (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/L NaCl, 2 mM MgSO4, and 100 μM CaCl2) supplemented with 5 g/L of casamino acids (BD Bioscience, USA), 5 g/L of glucose, and 50 μg/mL of ampicillin (and 10 μg/mL of kanamycin only for mutant strains) in 165-mL serum bottles (Wheaton, USA) at 37 °C and 220 rpm. When the cell density reached ~0.6 OD at 600 nm, the cultures were induced for hydrogenase expression and H2 production with the addition of 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG; Carbosynth, UK), 30 μM NiSO4, and 30 μM FeSO4. The bottles were tightly sealed with rubber stoppers and aluminum caps and cultivated for a further 16 h until H2 production was measured using gas chromatography (GC; Younglin Instrument, Korea).

FHL activity assay

After in vivo H2 production, cells were harvested by centrifugation at 4 °C and 4000×g for 10 min and washed with phosphate buffered saline (PBS; 8 g/L NaCl, 1.44 g/L Na2HPO4, 0.2 g/L KCl, and 0.24 g/L KH2PO4; pH 7.4). They were resuspended in 98 mL of PBS in the serum bottle with addition of 2 mL of 1 M sodium formate. Immediately after brief (~3 min) flushing with N2 gas, the bottle was sealed with a rubber stopper and an aluminum cap. After incubation at 37 °C and 220 rpm, the production of H2 from formate was analyzed from the gas phase of the bottle via GC.

H2 production measurement

The H2 production was measured as previously described [36]. In brief, a specific volume (usually 100 μL) of gas was sampled from the headspace of culture bottle and analyzed by GC to determine the partial H2 pressure. The total amount of H2 was calculated by multiplying the H2 concentration by the headspace volume of the bottle (65 mL).

Western blot analysis

Western blot analysis was performed for detection of hexahistidine (His6)-tagged proteins as previously described [36].

Formate measurement

Formate was measured by enzymatic assay using formate dehydrogenase as previously described [37] with slight modifications. Samples were diluted 1/10 with deionized water. A reaction solution containing 610 μL of 80 mM sodium phosphate buffer (pH 7.0), 300 μL of 10 mM nicotinamide adenine dinucleotide (NAD+; Sigma-Aldrich, USA) and 100 μL of formate dehydrogenase (~1 mg/mL; Sigma-Aldrich) was mixed with 25 μL of the diluted sample solution. After 2.5 h reaction at 37 °C, the absorbance change by formate-dependent NAD+ reduction was measured at 340 nm. Formate concentration was calculated based on the absorbance change and a standard curve prepared using sodium formate solutions (Sigma-Aldrich) with various concentrations.

Declarations

Authors’ contributions

BHJ and HJC designed the research. BHJ performed the experiments and analyzed the data. BHJ and HJC wrote the paper. Both authors read and approved the final manuscript.

Acknowledgements

This work was supported by the Energy Efficiency and Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Trade, Industry and Energy (20142020200980).

Compliance with ethical guidelines

Competing interests The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Chemical Engineering, Pohang University of Science and Technology

References

  1. Lee HS, Vermaas WFJ, Rittmann BE. Biological hydrogen production: prospects and challenges. Trends Biotechnol. 2010;28:262–71.View ArticleGoogle Scholar
  2. Mertens R, Liese A. Biotechnological applications of hydrogenases. Curr Opin Biotechnol. 2004;15:343–8.View ArticleGoogle Scholar
  3. Rousset M, Liebgott P. Engineering hydrogenases for H2 production: bolts and goals. In: Zannoni D, Philippis RD, editors. Microbial BioEnergy: hydrogen production. Dordrecht Netherlands: Springer; 2014. p. 43–77.View ArticleGoogle Scholar
  4. English CM, Eckert C, Brown K, Seibert M, King PW. Recombinant and in vitro expression systems for hydrogenases: new frontiers in basic and applied studies for biological and synthetic H2 production. Dalton Trans. 2009;45:9970–8.View ArticleGoogle Scholar
  5. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol. 2006;72:211–22.View ArticleGoogle Scholar
  6. Wells MA, Mercer J, Mott RA, Pereira-Medrano AG, Burja AM, Radianingtyas H, et al. Engineering a non-native hydrogen production pathway into Escherichia coli via a cyanobacterial [NiFe] hydrogenase. Metab Eng. 2011;13:445–53.View ArticleGoogle Scholar
  7. Sun JS, Hopkins RC, Jenney FE, McTernan PM, Adams MWW. Heterologous expression and maturation of an NADP-dependent [NiFe]-hydrogenase: a key enzyme in biofuel production. PLoS One. 2010;5:e10526.View ArticleGoogle Scholar
  8. Ghosh D, Bisaillon A, Hallenbeck PC. Increasing the metabolic capacity of Escherichia coli for hydrogen production through heterologous expression of the Ralstonia eutropha SH operon. Biotechnol Biofuels. 2013;6:122.View ArticleGoogle Scholar
  9. Akhtar MK, Jones PR. Construction of a synthetic YdbK-dependent pyruvate:H2 pathway in Escherichia coli BL21(DE3). Metab Eng. 2009;11:139–47.View ArticleGoogle Scholar
  10. Kim YM, Cho HS, Jung GY, Park JM. Engineering the pentose phosphate pathway to improve hydrogen yield in recombinant Escherichia coli. Biotechnol Bioeng. 2011;108:2941–6.View ArticleGoogle Scholar
  11. Pinske C, Bonn M, Kruger S, Lindenstrauss U, Sawers RG. Metabolic deficiences revealed in the biotechnologically important model bacterium Escherichia coli BL21(DE3). PLoS One. 2011;6:e22830.View ArticleGoogle Scholar
  12. Veit A, Akhtar MK, Mizutani T, Jones PR. Constructing and testing the thermodynamic limits of synthetic NAD(P)H:H2 pathways. Microb Biotechnol. 2008;1:382–94.View ArticleGoogle Scholar
  13. Mishra J, Khurana S, Kumar N, Ghosh AK, Das D. Molecular cloning, characterization, and overexpression of a novel [Fe]-hydrogenase from a high rate of hydrogen producing Enterobacter cloacae IIT-BT 08. Biochem Biophys Res Commun. 2004;324:679–85.View ArticleGoogle Scholar
  14. Akhtar MK, Jones PR. Deletion of iscR stimulates recombinant clostridial Fe-Fe hydrogenase activity and H2-accumulation in Escherichia coli BL21(DE3). Appl Microbiol Biotechnol. 2008;78:853–62.View ArticleGoogle Scholar
  15. Redood MD, Mikheenko IP, Sargent F, Macaskie LE. Dissecting the roles of Escherichia coli hydrogenases in biohydrogen production. FEMS Microbiol Lett. 2008;278:48–55.View ArticleGoogle Scholar
  16. Sawers RG. Formate and its role in hydrogen production in Escherichia coli. Biochem Soc Trans. 2005;33:42–6.View ArticleGoogle Scholar
  17. Kim JYH, Jo BH, Cha HJ. Production of biohydrogen by heterologous expression of oxygen-tolerant Hydrogenovibrio marinus [NiFe]-hydrogenase in Escherichia coli. J Biotechnol. 2011;155:312–9.View ArticleGoogle Scholar
  18. Lee SY, Lee HJ, Park JM, Lee JH, Park JS, Shin HS, et al. Bacterial hydrogen production in recombinant Escherichia coli harboring a HupSL hydrogenase isolated from Rhodobacter sphaeroides under anaerobic dark culture. Int J Hydrogen Energy. 2010;35:1112–6.View ArticleGoogle Scholar
  19. Kim JYH, Jo BH, Cha HJ. Production of biohydrogen by recombinant expression of [NiFe]-hydrogenase 1 in Escherichia coli. Microb Cell Fact. 2010;9:54.View ArticleGoogle Scholar
  20. Nishihara H, Miyata Y, Miyashita Y, Bernhard M, Pohlmann A, Friedrich B, et al. Analysis of the molecular species of hydrogenase in the cells of an obligately chemolithoautotrophic, marine hydrogen-oxidizing bacterium, Hydrogenovibrio marinus. Biosci Biotechnol Biochem. 2001;65:2780–4.View ArticleGoogle Scholar
  21. Lukey MJ, Parkin A, Roessler MM, Murphy BJ, Harmer J, Palmer T, et al. How Escherichia coli is equipped to oxidize hydrogen under different redox conditions. J Biol Chem. 2010;285:3928–38.View ArticleGoogle Scholar
  22. Koku H, Eroglu I, Gunduz U, Yucel M, Turker L. Aspects of the metabolism of hydrogen production by Rhodobacter sphaeroides. Int J Hydrogen Energy. 2002;27:1315–29.View ArticleGoogle Scholar
  23. Pandelia ME, Lubitz W, Nitschke W. Evolution and diversification of Group 1 [NiFe] hydrogenases. Is there a phylogenetic marker for O2-tolerance? BBA-Bioenergetics. 2012;1817:1565–75.View ArticleGoogle Scholar
  24. Abou Hamdan A, Dementin S, Liebgott PP, Gutierrez-Sanz O, Richaud P, De Lacey AL, et al. Understanding and tuning the catalytic bias of hydrogenase. J Am Chem Soc. 2012;134:8368–71.View ArticleGoogle Scholar
  25. Murphy BJ, Sargent F, Armstrong FA. Transforming an oxygen-tolerant [NiFe] uptake hydrogenase into a proficient, reversible hydrogen producer. Energy Environ Sci. 2014;7:1426–33.View ArticleGoogle Scholar
  26. Casalot L, Rousset M. Maturation of the [NiFe] hydrogenases. Trends Microbiol. 2001;9:228–37.View ArticleGoogle Scholar
  27. Zhou P, Wang YM, Gao R, Tong J, Yang ZY. Transferring [NiFe] hydrogenase gene from Rhodopeseudomonas palustris into E. coli BL21(DE3) for improving hydrogen production. Int J Hydrogen Energy. 2015;40:4329–36.View ArticleGoogle Scholar
  28. Vignais PM, Billoud B. Occurrence, classification, and biological function of hydrogenases: an overview. Chem Rev. 2007;107:4206–72.View ArticleGoogle Scholar
  29. Mergulhao FJM, Summers DK, Monteiro GA. Recombinant protein secretion in Escherichia coli. Biotechnol Adv. 2005;23:177–202.View ArticleGoogle Scholar
  30. Maeda T, Sanchez-Torres V, Wood TK. Hydrogen production by recombinant Escherichia coli strains. Microb Biotechnol. 2012;5:214–25.View ArticleGoogle Scholar
  31. Kim S, Seol E, Oh YK, Wang GY, Park S. Hydrogen production and metabolic flux analysis of metabolically engineered Escherichia coli strains. Int J Hydrogen Energy. 2009;34:7417–27.View ArticleGoogle Scholar
  32. Maeda T, Sanchez-Torres V, Wood TK. Enhanced hydrogen production from glucose by metabolically engineered Escherichia coli. Appl Microbiol Biotechnol. 2007;77:879–90.View ArticleGoogle Scholar
  33. Maeda T, Sanchez-Torres V, Wood TK. Escherichia coli hydrogenase 3 is a reversible enzyme possessing hydrogen uptake and synthesis activities. Appl Microbiol Biotechnol. 2007;76:1035–42.View ArticleGoogle Scholar
  34. Jo BH, Hwang BH, Cha HJ. Draft genome sequence of Hydrogenovibrio marinus MH-110, a model organism for aerobic H2 metabolism. J Biotechnol. 2014;185:37–8.View ArticleGoogle Scholar
  35. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97:6640–5.View ArticleGoogle Scholar
  36. Jo BH, Kim JYH, Seo JH, Cha HJ. Oxygen-dependent enhancement of hydrogen production by engineering bacterial hemoglobin in Escherichia coli. Int J Hydrogen Energy. 2014;39:10426–33.View ArticleGoogle Scholar
  37. Triebig G, Schaller KH. A simple and reliable enzymatic assay for the determination of formic acid in urine. Clin Chim Acta. 1980;108:355–60.View ArticleGoogle Scholar

Copyright

© Jo and Cha. 2015

Advertisement